Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin

被引：4
|
作者：
Bruno, S [1 ]
Crosignani, A
Pinzello, GB
机构：
[1] S Paolo Univ Milan, I-20142 Milan, Italy
[2] Crespi Niguarda Hosp Milan, Liver Unit, I-20100 Milan, Italy
来源：
ANNALS OF INTERNAL MEDICINE | 2000年 / 133卷 / 11期
关键词：
D O I：
10.7326/0003-4819-133-11-200012050-00025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [1] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [2] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [3] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [4] Impaired response to interferon-α2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection
    Aghemo, Alessio
    Rumi, Maria Grazia
    Soffredini, Roberto
    D'Ambrosio, Roberta
    Ronchi, Guido
    Del Ninno, Ersilio
    Gallus, Silvana
    Colombo, Massimo
    ANTIVIRAL THERAPY, 2006, 11 (06) : 797 - 802
  • [5] Hepatitis C virus genotype 5:: Epidemiological characteristics and sensitivity to combination therapy with interferon-α plus ribavirin
    Legrand-Abravanel, F
    Sandres-Sauné, K
    Barange, K
    Alric, L
    Moreau, J
    Desmorat, P
    Vinel, JP
    Izopet, J
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08): : 1397 - 1400
  • [6] Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (10) : 1593 - 1599
  • [7] Therapy of acute hepatitis C with interferon-α2b plus ribavirin in a health care worker
    Ertem, GT
    Tulek, N
    Oral, B
    Kinikli, S
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (01) : 104 - 106
  • [8] Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks
    Wada, Yuki
    Tamai, Hideyuki
    Uno, Akiko
    Kawashima, Akira
    Shingaki, Naoki
    Mori, Yoshiyuki
    Moribata, Kosaku
    Miyata, Kaori
    Higashi, Katsuhiko
    Deguchi, Hisanobu
    Ueda, Kazuki
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    HEPATOLOGY RESEARCH, 2014, 44 (02) : 179 - 186
  • [9] Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection
    Hung, CH
    Lee, CM
    Lu, SN
    Wang, JH
    Tung, HD
    Chen, CH
    Changchien, CS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (05) : 727 - 732
  • [10] High-dose interferon-α2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection -: A study in patients with chronic hepatitis C
    Cheng, PN
    Jen, CM
    Young, KC
    Chen, CY
    Lu, SN
    Wang, CS
    Chang, TT
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 449 - 452
12345